To establish an effective and reliable system for the detection of p53
mutations, we evaluated the detection efficiencies of nonisotopic pol
ymerase chain reaction-single-strand conformation polymorphism (PCR-SS
CP), fluorescence in situ hybridization (FISH), and immunohistochemist
ry. Ten cell lines (AsPc1, BxPc3, Miapaca2, Pane1, Colo320-011, Love,
MCF7, LNCaP, HL-60, and Daudi), a peripheral blood sample from a patie
nt with a p53 germline mutation (p53GML), and a normal peripheral bloo
d sample were used for examination. Direct nucleotide sequencing ident
ified p53 mutations in 7 of 12 samples (AsPc1, BxPc3, Miapaca2, Pane1,
Colo320-011, HL-60, and p53GML). The nonisotopic PCR-SSCP detected an
omalies of the PCR fragments in 5 cell lines. In the FISH analysis, 2
cell lines exhibited loss of heterozygosity of the p53 locus. Immunohi
stochemistry detected an accumulation of the abnormal p53 in 4 cell li
nes. The combination of these 3 methods produced no false-negative or
false-positive results. This combination may be an excellent and benef
icial system for the clinical diagnosis of the various human cancers.